EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study of Acute and Late Side Effects in Breast Cancer Patients Treated with Ultra-Hypo-Fractionated Radiation Therapy

Muhammad Ikrama Tanveer, Daniyal Ahmed Sami, Anusha Haider, Maria Qureshi

Journal of Health, Wellness and Community Research · 30.03.2026 · 1-9

DOI: 10.61919/t7espy64 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Health, Wellness and Community Research, online erschienen am 30.03.2026. Verfasst von Muhammad Ikrama Tanveer und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer imposes a substantial clinical burden in Pakistan, and shorter radiotherapy schedules may improve patient convenience and optimize limited oncology resources. Ultra-hypofractionated breast radiotherapy has gained increasing acceptance internationally, but local real-world toxicity data remain limited.

Objective

To evaluate the acute and late side effects of ultra-hypofractionated adjuvant breast radiotherapy in patients with breast cancer treated at a tertiary cancer center in Pakistan.

Methods

This retrospective observational study included 86 adult female patients with node-negative breast cancer treated between January 2021 and December 2022 with 26 Gy in 5 fractions, with or without a boost of 10 Gy in 5 fractions. Toxicities were assessed using Common Terminology Criteria for Adverse Events version 5 at the end of treatment, 4, 8, and 12 weeks, and at 6 and 12 months.

Results

The mean age was 43.8 years. Most patients received field-in-field radiotherapy (82.6%). Radiation dermatitis was the most frequent acute toxicity, with 59.3% Grade 0, 38.4% Grade 1, and 2.3% Grade 2 events; no Grade 3-4 dermatitis occurred. Radiation pneumonitis was observed in 4.7%, acute lymphedema in 2.3%, and skin hyperpigmentation in 2.3%, all of low grade. Among 57 patients with long-term follow-up, breast fibrosis occurred in 14.0% and late lymphedema in 3.5%.

Conclusion

Ultra-hypofractionated breast radiotherapy showed an overall favorable and clinically manageable toxicity profile in this cohort, supporting its practical use in routine care, although larger prospective comparative studies are needed.

Zitieren

APA

Tanveer, M. I., Sami, D. A., Haider, A., & Qureshi, M. (2026). Study of Acute and Late Side Effects in Breast Cancer Patients Treated with Ultra-Hypo-Fractionated Radiation Therapy. Journal of Health, Wellness and Community Research, 1-9. https://doi.org/10.61919/t7espy64

Vancouver

Tanveer MI, Sami DA, Haider A, Qureshi M. Study of Acute and Late Side Effects in Breast Cancer Patients Treated with Ultra-Hypo-Fractionated Radiation Therapy. Journal of Health, Wellness and Community Research. 2026:1-9. doi:10.61919/t7espy64

BibTeX
@article{Tanveer2026,
  author = {Tanveer, Muhammad Ikrama and Sami, Daniyal Ahmed and Haider, Anusha and Qureshi, Maria},
  title = {Study of Acute and Late Side Effects in Breast Cancer Patients Treated with Ultra-Hypo-Fractionated Radiation Therapy},
  journal = {Journal of Health, Wellness and Community Research},
  year = {2026},
  pages = {1--9},
  doi = {10.61919/t7espy64}
}
Kostenlos starten →